Healthy volunteers help test new drug's journey through the body
NCT ID NCT07361354
First seen Jan 27, 2026 · Last updated May 09, 2026 · Updated 13 times
Summary
This early-phase study looks at how a single dose of AGA2118 moves through and leaves the body in 30 healthy adults of Japanese, Chinese, and Caucasian descent. Participants must be 18-65, have adequate vitamin D levels, and agree to take calcium and vitamin D supplements. The study does not aim to treat any disease, only to gather safety and drug-processing information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Los Angeles EPCU
RECRUITINGGlendale, California, 91206, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.